January 3, 2018 / 2:33 PM / in 12 minutes BRIEF-Quest Pharmatech Unit Sign License Agreement With Stanford University Reuters Staff 1 Min Read 
Jan 3 (Reuters) - Quest Pharmatech Inc: 
* QUEST PHARMATECH- UNIT SIGN EXCLUSIVE LICENSE AGREEMENT WITH STANFORD UNIVERSITY TO DEVELOP & COMMERCIALIZE PATENTED EGF WOUND HEALING TECHNOLOGY Source text for Eikon: Further company coverage: